Personalized Chemosensitivity Assays for Mesothelioma: Are They Worth the Effort?

Clin Cancer Res. 2018 Apr 1;24(7):1513-1515. doi: 10.1158/1078-0432.CCR-17-3493. Epub 2018 Jan 19.

Abstract

Cell lines formed from an individual's tumor can be used to predict response to specific therapies and determine genomic predictors. For mesothelioma, where chemotherapy remains the backbone of current therapeutic paradigms, such assays could be used to treat patients with the most effective agents specific to their "chemical profile." Clin Cancer Res; 24(7); 1513-5. ©2018 AACRSee related article by Schunselaar et al., p. 1761.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Lung Neoplasms*
  • Mesothelioma*